UA66767C2
(uk)
*
|
1996-10-18 |
2004-06-15 |
Вертекс Фармасьютикалс Інкорпорейтед |
Інгібітори серин-протеаз, фармацевтична композиція, спосіб інгібування активності та спосіб лікування або профілактики вірусної інфекції гепатиту с
|
JP2001508767A
(ja)
*
|
1996-12-02 |
2001-07-03 |
藤沢薬品工業株式会社 |
5―ht拮抗作用を有するインドール―ウレア誘導体
|
EP1366766A1
(en)
*
|
1997-03-14 |
2003-12-03 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of IMPDH enzyme
|
WO2000024707A1
(en)
*
|
1998-10-22 |
2000-05-04 |
Neurosearch A/S |
Substituted phenyl derivatives, their preparation and use
|
US6093742A
(en)
*
|
1997-06-27 |
2000-07-25 |
Vertex Pharmaceuticals, Inc. |
Inhibitors of p38
|
SK5462000A3
(en)
|
1997-10-31 |
2001-02-12 |
Aventis Pharma Ltd |
Substituted anilides
|
CN1149085C
(zh)
*
|
1997-12-22 |
2004-05-12 |
拜尔有限公司 |
用取代杂环脲抑制raf激酶
|
US7517880B2
(en)
|
1997-12-22 |
2009-04-14 |
Bayer Pharmaceuticals Corporation |
Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas
|
ATE346600T1
(de)
*
|
1997-12-22 |
2006-12-15 |
Bayer Pharmaceuticals Corp |
Inhibierung der p38 kinase-aktivität durch die verwendung von aryl- und heteroarylsubstituierten harnstoffen
|
US7329670B1
(en)
|
1997-12-22 |
2008-02-12 |
Bayer Pharmaceuticals Corporation |
Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureas
|
AU3665199A
(en)
*
|
1998-04-29 |
1999-11-16 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of impdh enzyme
|
US6313071B1
(en)
*
|
1998-06-04 |
2001-11-06 |
Kumiai Chemical Industry Co., Ltd. |
Phenylacetylene derivatives and agricultural/horticultural fungicides
|
CA2348267A1
(en)
|
1998-10-29 |
2000-05-11 |
Henry H. Gu |
Novel inhibitors of impdh enzyme
|
EP1126843A4
(en)
|
1998-10-29 |
2005-06-15 |
Bristol Myers Squibb Co |
AMINO-CELL DERIVATIVE COMPOUNDS INHIBITORS OF ENZYME IMPDH
|
US6420403B1
(en)
|
1998-10-29 |
2002-07-16 |
Edwin J. Iwanowicz |
Inhibitors of IMPDH enzyme
|
US6596747B2
(en)
|
1998-10-29 |
2003-07-22 |
Bristol-Myers Squibb Company |
Compounds derived from an amine nucleus and pharmaceutical compositions comprising same
|
GB9823873D0
(en)
|
1998-10-30 |
1998-12-30 |
Pharmacia & Upjohn Spa |
2-ureido-thiazole derivatives,process for their preparation,and their use as antitumour agents
|
RU2233269C2
(ru)
*
|
1998-11-02 |
2004-07-27 |
Авентис Фарма Лимитед |
Замещенные анилиды, фармацевтическая композиция и способ лечения
|
CZ20012067A3
(cs)
*
|
1998-12-09 |
2001-10-17 |
American Home Products Corporation |
Thiomočovinové sloučeniny obsahující alfa methylbenzylovou skupinu a fenylendiaminovou skupinu jako inhibitory herpes virů
|
US6262090B1
(en)
|
1998-12-09 |
2001-07-17 |
American Home Products Corporation |
Aminopyridine-containing thiourea inhibitors of herpes viruses
|
US6166028A
(en)
|
1998-12-09 |
2000-12-26 |
American Home Products Corporation |
Diaminopuridine-containing thiourea inhibitors of herpes viruses
|
US6201013B1
(en)
|
1998-12-09 |
2001-03-13 |
American Home Products Corporation |
Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing a substituted phenylenediamine group
|
NZ512108A
(en)
*
|
1998-12-09 |
2003-09-26 |
Wyeth Corp |
Thiourea inhibitors of herpes viruses
|
US6337338B1
(en)
|
1998-12-15 |
2002-01-08 |
Telik, Inc. |
Heteroaryl-aryl ureas as IGF-1 receptor antagonists
|
AU1689600A
(en)
*
|
1998-12-22 |
2000-07-12 |
Mitsubishi Chemical Corporation |
Amide derivatives
|
US8124630B2
(en)
|
1999-01-13 |
2012-02-28 |
Bayer Healthcare Llc |
ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
|
EP1140840B1
(en)
|
1999-01-13 |
2006-03-22 |
Bayer Pharmaceuticals Corp. |
-g(v)-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
|
US7928239B2
(en)
|
1999-01-13 |
2011-04-19 |
Bayer Healthcare Llc |
Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureas
|
IL144144A0
(en)
|
1999-01-13 |
2002-05-23 |
Bayer Ag |
Omega-carboxy aryl substituted diphenyl ureas as p38 kinase inhibitors
|
ME00275B
(me)
|
1999-01-13 |
2011-02-10 |
Bayer Corp |
ω-KARBOKSIARIL SUPSTITUISANI DIFENIL KARBAMIDI KAO INHIBITORI RAF KINAZE
|
SG142120A1
(en)
*
|
1999-03-12 |
2008-05-28 |
Boehringer Ingelheim Pharma |
Compounds useful as anti-inflammatory agents
|
HUP0201214A3
(en)
*
|
1999-03-19 |
2002-11-28 |
Vertex Pharmaceuticals Inc Cam |
Inhibitors of impdh enzyme, pharmaceutical compositions containing them and their use
|
US6653309B1
(en)
|
1999-04-26 |
2003-11-25 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of IMPDH enzyme technical field of the invention
|
WO2000073288A1
(en)
*
|
1999-05-28 |
2000-12-07 |
Vertex Pharmaceuticals Incorporated |
Method for preparing 5-substituted oxazoles
|
US6107052A
(en)
*
|
1999-06-09 |
2000-08-22 |
Roche Diagnostics Corporation |
Enzymatic measurement of mycophenolic acid
|
DE60005017T2
(de)
*
|
1999-06-25 |
2004-06-09 |
Vertex Pharmaceuticals Inc., Cambridge |
Prodrugs von impdh-inhibierenden carbamaten
|
JP2001011059A
(ja)
*
|
1999-06-28 |
2001-01-16 |
Nippon Synthetic Chem Ind Co Ltd:The |
5−(2−置換−4−ニトロフェニル)−オキサゾールの製造方法
|
JP2001011060A
(ja)
*
|
1999-06-28 |
2001-01-16 |
Nippon Synthetic Chem Ind Co Ltd:The |
新規オキサゾール化合物及びその製造方法
|
TWI262185B
(en)
*
|
1999-10-01 |
2006-09-21 |
Eisai Co Ltd |
Carboxylic acid derivatives having anti-hyperglycemia and anti-hyperlipemia action, and pharmaceutical composition containing the derivatives
|
US6867299B2
(en)
|
2000-02-24 |
2005-03-15 |
Hoffmann-La Roche Inc. |
Oxamide IMPDH inhibitors
|
AU2001255538B2
(en)
*
|
2000-04-24 |
2006-03-30 |
Bristol-Myers Squibb Company |
Heterocycles that are inhibitors of IMPDH enzyme
|
SV2003000617A
(es)
*
|
2000-08-31 |
2003-01-13 |
Lilly Co Eli |
Inhibidores de la proteasa peptidomimetica ref. x-14912m
|
US6423849B1
(en)
*
|
2000-09-01 |
2002-07-23 |
The Nippon Synthetic Chemical Industry Co., Ltd. |
Process of preparing 5-(2-substituted-4-nitrophenyl)-oxazole, novel oxazole compound, and process of preparing the same
|
US7235576B1
(en)
|
2001-01-12 |
2007-06-26 |
Bayer Pharmaceuticals Corporation |
Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
|
US7371763B2
(en)
|
2001-04-20 |
2008-05-13 |
Bayer Pharmaceuticals Corporation |
Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas
|
US6593362B2
(en)
*
|
2001-05-21 |
2003-07-15 |
Guilford Pharmaceuticals Inc. |
Non-peptidic cyclophilin binding compounds and their use
|
TW200301698A
(en)
|
2001-12-21 |
2003-07-16 |
Bristol Myers Squibb Co |
Acridone inhibitors of IMPDH enzyme
|
MXPA04007830A
(es)
|
2002-02-11 |
2005-07-01 |
Bayer Pharmaceuticals Corp |
Arilureas como inhibidores de cinasa.
|
MXPA04007832A
(es)
|
2002-02-11 |
2005-09-08 |
Bayer Pharmaceuticals Corp |
Aril-ureas con actividad inhibitoria de angiogenesis.
|
EP1402887A1
(en)
*
|
2002-09-18 |
2004-03-31 |
Jerini AG |
New compounds for the inhibition of undesired cell proliferation and use thereof
|
AU2003298868B2
(en)
|
2002-12-06 |
2009-09-17 |
Vertex Pharmaceuticals Incorporated |
Compositions comprising a combination of diphenyl ura IMPDH inhibitors and apoptosis-inducing anti-cancer agents
|
AU2003300076C1
(en)
|
2002-12-30 |
2010-03-04 |
Angiotech International Ag |
Drug delivery from rapid gelling polymer composition
|
US7220768B2
(en)
*
|
2003-02-11 |
2007-05-22 |
Wyeth Holdings Corp. |
Isoxazole-containing thiourea inhibitors useful for treatment of varicella zoster virus
|
PL1626714T3
(pl)
|
2003-05-20 |
2007-12-31 |
Bayer Healthcare Llc |
Diarylowe pochodne mocznika do schorzeń, w których pośredniczy PDGFR
|
US8637553B2
(en)
|
2003-07-23 |
2014-01-28 |
Bayer Healthcare Llc |
Fluoro substituted omega-carboxyaryl diphenyl urea for the treatment and prevention of diseases and conditions
|
PE20050374A1
(es)
*
|
2003-09-05 |
2005-05-30 |
Vertex Pharma |
Inhibidores de proteasas de serina, en particular proteasa ns3-ns4a del vhc
|
CN101857631A
(zh)
|
2003-10-10 |
2010-10-13 |
沃泰克斯药物股份有限公司 |
丝氨酸蛋白酶、特别是hcv ns3-ns4a蛋白酶的抑制剂
|
AR045870A1
(es)
*
|
2003-10-11 |
2005-11-16 |
Vertex Pharma |
Terapia de combinacion para la infeccion de virus de hepatitis c
|
EP1944042A1
(en)
|
2003-10-27 |
2008-07-16 |
Vertex Pharmceuticals Incorporated |
Combinations for HCV treatment
|
KR20060120166A
(ko)
*
|
2003-10-27 |
2006-11-24 |
버텍스 파마슈티칼스 인코포레이티드 |
Hcv ns3-ns4a 단백질분해효소 저항성 돌연변이
|
CN1938332B
(zh)
|
2004-02-04 |
2011-10-19 |
沃泰克斯药物股份有限公司 |
丝氨酸蛋白酶、特别是hcv ns3-ns4a蛋白酶的抑制剂
|
US7317030B2
(en)
|
2004-02-26 |
2008-01-08 |
4Sc Ag |
Compounds as inhibitors of cell proliferation and viral infections
|
EP1568696A1
(en)
*
|
2004-02-26 |
2005-08-31 |
4Sc Ag |
Compounds as inhibitors of cell proliferation and viral infections
|
US20110104186A1
(en)
|
2004-06-24 |
2011-05-05 |
Nicholas Valiante |
Small molecule immunopotentiators and assays for their detection
|
NZ552868A
(en)
|
2004-08-12 |
2009-07-31 |
Pfizer |
Triazolopyridinylsulfanyl derivatives as P38 MAP kinase inhibitors
|
EP1804821A4
(en)
|
2004-10-01 |
2009-07-15 |
Vertex Pharma |
INHIBITION OF HCV NS3-NS4A PROTEASE
|
TWI437990B
(zh)
|
2004-10-29 |
2014-05-21 |
Vertex Pharma |
Vx-950之醫藥用途
|
ES2465469T3
(es)
*
|
2005-01-14 |
2014-06-05 |
Gilead Connecticut, Inc. |
Diaril ureas 1,3-sustituidas como moduladores de la actividad quinasa
|
EP1858879B1
(en)
*
|
2005-01-14 |
2012-06-06 |
Gilead Connecticut, Inc. |
1,3-diaryl substituted ureas as modulators of kinase activity
|
US20060235070A1
(en)
*
|
2005-02-08 |
2006-10-19 |
Hayden Michael R |
Compositions and methods for treating vascular, autoimmune, and inflammatory diseases
|
WO2006086498A2
(en)
*
|
2005-02-08 |
2006-08-17 |
Aspreva Pharmaceuticals Sa |
Treatment of vascular, autoimmune and inflammatory diseases using low dosages of impdh inhibitors
|
WO2006094626A1
(en)
|
2005-03-07 |
2006-09-14 |
Bayer Healthcare Ag |
Pharmaceutical composition comprising an omega- carboxyaryl substituted diphenyl urea for the treatment of cancer
|
WO2007024294A2
(en)
*
|
2005-05-03 |
2007-03-01 |
Cgi Pharmaceuticals, Inc. |
Certain substituted ureas, as modulators of kinase activity
|
BRPI0608602A2
(pt)
|
2005-05-09 |
2010-01-19 |
Vertex Pharma |
processos para a preparaÇço de urÉias de biarila e anÁlogos dos mesmos
|
JP2008540538A
(ja)
*
|
2005-05-09 |
2008-11-20 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
(s)−3−(3−(3−メトキシ−4−(オキサゾール−5−イル)フェニル)ウレイド)ベンジルカルバミン酸テトラヒドロフラン−3−イルの多形形態
|
JP5426164B2
(ja)
|
2005-07-29 |
2014-02-26 |
ヤンセン・アールアンドデイ・アイルランド |
C型肝炎ウイルスの大環式インヒビター
|
JO2768B1
(en)
|
2005-07-29 |
2014-03-15 |
تيبوتيك فارماسيوتيكالز ليمتد |
Large cyclic inhibitors of hepatitis C virus
|
MY139923A
(en)
|
2005-07-29 |
2009-11-30 |
Tibotec Pharm Ltd |
Macrocylic inhibitors of hepatitis c virus
|
RU2436787C2
(ru)
|
2005-07-29 |
2011-12-20 |
Тиботек Фармасьютикалз Лтд. |
Макроциклические ингибиторы вируса гепатита с
|
PE20070211A1
(es)
|
2005-07-29 |
2007-05-12 |
Medivir Ab |
Compuestos macrociclicos como inhibidores del virus de hepatitis c
|
PE20070210A1
(es)
|
2005-07-29 |
2007-04-16 |
Tibotec Pharm Ltd |
Compuestos macrociclicos como inhibidores del virus de hepatitis c
|
CA2617099C
(en)
|
2005-07-29 |
2014-03-25 |
Tibotec Pharmaceuticals Ltd. |
Macrocyclic inhibitors of hepatitis c virus
|
TWI393723B
(zh)
|
2005-07-29 |
2013-04-21 |
Tibotec Pharm Ltd |
C型肝炎病毒之大環抑制劑(九)
|
SI1919898T1
(sl)
|
2005-07-29 |
2011-05-31 |
Tibotec Pharm Ltd |
Makrociklični inhibitorji virusa hepatitisa C
|
KR20080033481A
(ko)
|
2005-08-02 |
2008-04-16 |
버텍스 파마슈티칼스 인코포레이티드 |
세린 프로테아제의 억제제
|
AR055395A1
(es)
*
|
2005-08-26 |
2007-08-22 |
Vertex Pharma |
Compuestos inhibidores de la actividad de la serina proteasa ns3-ns4a del virus de la hepatitis c
|
US7964624B1
(en)
*
|
2005-08-26 |
2011-06-21 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of serine proteases
|
EP2392590A3
(en)
|
2005-11-11 |
2012-03-14 |
Vertex Pharmaceuticals Incorporated |
Hepatitis C virus variants
|
US7705138B2
(en)
|
2005-11-11 |
2010-04-27 |
Vertex Pharmaceuticals Incorporated |
Hepatitis C virus variants
|
EP1991229A2
(en)
|
2006-02-27 |
2008-11-19 |
Vertex Pharmaceuticals Incorporated |
Co-crystals and pharmaceutical compositions comprising the same
|
EP1993994A2
(en)
|
2006-03-16 |
2008-11-26 |
Vertex Pharmceuticals Incorporated |
Deuterated hepatitis c protease inhibitors
|
EP2007789B1
(en)
|
2006-04-11 |
2015-05-20 |
Novartis AG |
Spirocyclic HCV/HIV inhibitors and their uses
|
US20080076770A1
(en)
*
|
2006-09-25 |
2008-03-27 |
Arete Therapeutics, Inc. |
Soluble epoxide hydrolase inhibitors
|
US9987277B2
(en)
|
2006-10-04 |
2018-06-05 |
Janssen Sciences Ireland Uc |
Carboxamide 4-[(4-pyridyl)amino] pryimidines for the treatment of hepatitis C
|
CN101535294B
(zh)
|
2006-11-17 |
2014-09-24 |
泰博特克药品有限公司 |
丙型肝炎病毒的大环化合物抑制剂
|
EP2134717A2
(en)
*
|
2007-02-27 |
2009-12-23 |
Vertex Pharmceuticals Incorporated |
Inhibitors of serine proteases
|
GEP20125645B
(en)
*
|
2007-02-27 |
2012-09-25 |
Vertex Pharma |
Co-crystals and pharmaceutical compositions comprising the same
|
EP2146717A4
(en)
*
|
2007-04-20 |
2010-08-11 |
Deciphera Pharmaceuticals Llc |
KINASE INHIBITORS USEFUL FOR THE TREATMENT OF MYOLEOPROLIFERATIVE DISEASES AND OTHER PROLIFERATIVE DISEASES
|
EP2142215B1
(en)
|
2007-05-04 |
2012-03-07 |
Vertex Pharmceuticals Incorporated |
Combination therapy for the treatment of hcv infection
|
EP2185546B1
(en)
*
|
2007-08-30 |
2011-10-26 |
Vertex Pharmceuticals Incorporated |
Co-crystals and pharmaceutical compositions comprising the same
|
CN101910177B
(zh)
|
2007-12-24 |
2013-08-28 |
泰博特克药品公司 |
作为丙型肝炎病毒抑制剂的大环吲哚
|
TWI454476B
(zh)
|
2008-07-08 |
2014-10-01 |
Tibotec Pharm Ltd |
用作c型肝炎病毒抑制劑之巨環吲哚衍生物
|
PL2331554T3
(pl)
|
2008-08-14 |
2013-08-30 |
Janssen R&D Ireland |
Makrocykliczne pochodne indolu użyteczne jako inhibitory wirusa zapalenia wątroby typu C
|
WO2010065674A1
(en)
|
2008-12-03 |
2010-06-10 |
Presidio Pharmaceuticals, Inc. |
Inhibitors of hcv ns5a
|
AU2009322387A1
(en)
|
2008-12-03 |
2011-06-30 |
Presidio Pharmaceuticals, Inc. |
Inhibitors of HCV NS5A
|
EP2396028A2
(en)
|
2009-02-12 |
2011-12-21 |
Vertex Pharmceuticals Incorporated |
Hcv combination therapies comprising pegylated interferon, ribavirin and telaprevir
|
US8969342B2
(en)
|
2009-03-20 |
2015-03-03 |
Brandeis University |
Compounds and methods for treating mammalian gastrointestinal microbial infections
|
CN102427726B
(zh)
|
2009-03-27 |
2014-10-08 |
普雷西迪奥制药公司 |
丙型肝炎的稠环抑制剂
|
US8512690B2
(en)
|
2009-04-10 |
2013-08-20 |
Novartis Ag |
Derivatised proline containing peptide compounds as protease inhibitors
|
US20110182850A1
(en)
|
2009-04-10 |
2011-07-28 |
Trixi Brandl |
Organic compounds and their uses
|
WO2011014882A1
(en)
|
2009-07-31 |
2011-02-03 |
Medtronic, Inc. |
CONTINUOUS SUBCUTANEOUS ADMINISTRATION OF INTERFERON-α TO HEPATITIS C INFECTED PATIENTS
|
UA108211C2
(uk)
|
2009-11-04 |
2015-04-10 |
Янссен Рід Айрленд |
Бензімідазолімідазольні похідні
|
RU2012136824A
(ru)
|
2010-01-29 |
2014-03-10 |
Вертекс Фармасьютикалз Инкорпорейтед |
Способы лечения вирусной инфекции гепатита с
|
WO2011112516A1
(en)
|
2010-03-08 |
2011-09-15 |
Ico Therapeutics Inc. |
Treating and preventing hepatitis c virus infection using c-raf kinase antisense oligonucleotides
|
US8877707B2
(en)
|
2010-05-24 |
2014-11-04 |
Presidio Pharmaceuticals, Inc. |
Inhibitors of HCV NS5A
|
MX342405B
(es)
|
2010-06-03 |
2016-09-28 |
Pharmacyclics Inc |
El uso de inhibidores de la tirosina quinasa de bruton (btk).
|
WO2011156545A1
(en)
|
2010-06-09 |
2011-12-15 |
Vertex Pharmaceuticals Incorporated |
Viral dynamic model for hcv combination therapy
|
MX2012015198A
(es)
|
2010-06-24 |
2013-02-11 |
Janssen R & D Ireland |
Preparacion de acido 13-ciclohexil-3-metoxi-6-[metil-(2-{2-[metil- (sulfamoil)-amino]-etoxi}-etil)-carbomoil]-7h-indolo-[2,1-a]-[2]- benzazepin-10-carboxilico.
|
AR082215A1
(es)
|
2010-07-14 |
2012-11-21 |
Vertex Pharma |
Composicion farmaceutica agradable al paladar
|
WO2012020036A1
(en)
|
2010-08-13 |
2012-02-16 |
F. Hoffmann-La Roche Ag |
Hepatitis c virus inhibitors
|
WO2012109646A1
(en)
|
2011-02-11 |
2012-08-16 |
Vertex Pharmaceuticals Incorporated |
Treatment of hcv in hiv infection patients
|
WO2012116370A1
(en)
|
2011-02-25 |
2012-08-30 |
Medtronic, Inc. |
Methods and systems using pharmacokinetic and pharmacodynamic profiles in interferon-alpha therapeutic regimens
|
WO2012123298A1
(en)
|
2011-03-11 |
2012-09-20 |
F. Hoffmann-La Roche Ag |
Antiviral compounds
|
BR112013032188A2
(pt)
|
2011-06-23 |
2016-12-20 |
Digna Biotech Sl |
composição, produto e método para tratar pacientes com hepatite c crônica
|
US20120328565A1
(en)
|
2011-06-24 |
2012-12-27 |
Brinkman John A |
Antiviral compounds
|
CN103917541B
(zh)
|
2011-10-10 |
2016-08-17 |
弗·哈夫曼-拉罗切有限公司 |
抗病毒化合物
|
JP5923181B2
(ja)
|
2011-12-16 |
2016-05-24 |
エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft |
Hcvns5aの阻害剤
|
KR101687084B1
(ko)
|
2011-12-20 |
2016-12-15 |
리보사이언스 엘엘씨 |
Hcv rna 복제의 억제제로서 4'-아지도, 3'-플루오로 치환된 뉴클레오시드 유도체
|
SI2794629T1
(sl)
|
2011-12-20 |
2017-10-30 |
Riboscience Llc |
2'4'-difluoro-2'-metil substituirani nukleozidni derivati k0t zaviralci replikacije hcv-rna
|
CN104203940B
(zh)
|
2011-12-28 |
2017-01-18 |
爱尔兰詹森科学公司 |
作为hcv抑制剂的杂双环衍生物
|
WO2013116339A1
(en)
|
2012-01-31 |
2013-08-08 |
Vertex Pharmaceuticals Incorporated |
High potency formulations of vx-950
|
MX2014009799A
(es)
|
2012-02-24 |
2014-09-08 |
Hoffmann La Roche |
Compuestos antivirales.
|
US8461179B1
(en)
|
2012-06-07 |
2013-06-11 |
Deciphera Pharmaceuticals, Llc |
Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases
|
US20140010783A1
(en)
|
2012-07-06 |
2014-01-09 |
Hoffmann-La Roche Inc. |
Antiviral compounds
|
CA2879570A1
(en)
|
2012-07-24 |
2014-01-30 |
Pharmacyclics, Inc. |
Mutations associated with resistance to inhibitors of bruton's tyrosine kinase (btk)
|
US9447134B2
(en)
|
2012-08-17 |
2016-09-20 |
Brandeis University |
Compounds and methods for treating mammalian gastrointestinal microbial infections
|
US20140205566A1
(en)
|
2012-11-30 |
2014-07-24 |
Novartis Ag |
Cyclic nucleuoside derivatives and uses thereof
|
EP2948440B1
(en)
|
2013-01-23 |
2017-04-12 |
F. Hoffmann-La Roche AG |
Antiviral triazole derivatives
|
BR112015021429A2
(pt)
|
2013-03-05 |
2017-07-18 |
Hoffmann La Roche |
compostos antivirais
|
BR112015028764B1
(pt)
|
2013-05-16 |
2022-09-27 |
Riboscience Llc |
Derivados de nucleosídeo de 4-fluoro-2-metil substituídos como inibidores de replicação de rna do hcv
|
US20180200280A1
(en)
|
2013-05-16 |
2018-07-19 |
Riboscience Llc |
4'-Fluoro-2'-Methyl Substituted Nucleoside Derivatives as Inhibitors of HCV RNA Replication
|
MA38678A1
(fr)
|
2013-05-16 |
2017-07-31 |
Riboscience Llc |
Dérivés nucléosidiques 4'-azido, 3'désoxy-3'-fluoro substitués
|
JP6508785B2
(ja)
|
2013-10-25 |
2019-05-08 |
ファーマサイクリックス エルエルシー |
ブルトンチロシンキナーゼ阻害剤および免疫療法を使用する処置
|
US9885086B2
(en)
|
2014-03-20 |
2018-02-06 |
Pharmacyclics Llc |
Phospholipase C gamma 2 and resistance associated mutations
|
JP7299897B2
(ja)
|
2017-09-21 |
2023-06-28 |
リボサイエンス リミティド ライアビリティ カンパニー |
Hcvのrna複製阻害剤としての4’-フルオロ-2’-メチル置換ヌクレオシド誘導体
|
KR102708050B1
(ko)
|
2018-01-31 |
2024-09-24 |
데시페라 파마슈티칼스, 엘엘씨. |
비만 세포증의 치료를 위한 병용 요법
|
BR112020015581A2
(pt)
|
2018-01-31 |
2021-02-02 |
Deciphera Pharmaceuticals, Llc |
terapia de combinação para o tratamento de tumores estromais gastrointestinais
|
AU2019242628A1
(en)
|
2018-03-26 |
2020-09-24 |
Clear Creek Bio, Inc. |
Compositions and methods for inhibiting dihydroorotate dehydrogenase
|
CN109970675A
(zh)
*
|
2018-05-28 |
2019-07-05 |
中国医学科学院医药生物技术研究所 |
一组硫脲化合物及其制备方法和应用
|
MY201990A
(en)
|
2018-06-19 |
2024-03-27 |
Novartis Ag |
N-substituted tetrahydrothienopyridine derivatives and uses thereof
|
US12098117B2
(en)
*
|
2018-12-11 |
2024-09-24 |
Duke University |
Compositions and methods for the treatment of cancer
|
TWI878335B
(zh)
|
2019-08-12 |
2025-04-01 |
美商迪賽孚爾製藥有限公司 |
治療胃腸道基質瘤方法
|
CA3150433A1
(en)
|
2019-08-12 |
2021-02-18 |
Deciphera Pharmaceuticals, Llc |
Ripretinib for treating gastrointestinal stromal tumors
|
CN110590535A
(zh)
*
|
2019-10-12 |
2019-12-20 |
重庆医药高等专科学校 |
用二氧化硒氧化芳香乙酮制备芳香乙醛酸的方法
|
HRP20231699T1
(hr)
|
2019-12-30 |
2024-05-10 |
Deciphera Pharmaceuticals, Llc |
Formulacije inhibitora amorfne kinaze i postupci njihove primjene
|
PL4084779T3
(pl)
|
2019-12-30 |
2025-02-24 |
Deciphera Pharmaceuticals, Llc |
Kompozycje 1-(4-bromo-5-(1-etylo-7-(metyloamino)-2-okso-1,2-dihydro-1,6-naftyrydyn-3-ylo)-2-fluorofenylo)-3-fenylomocznika
|
US20210315880A1
(en)
|
2020-03-20 |
2021-10-14 |
Clear Creek Bio, Inc. |
Methods of treating viral infections using inhibitors of nucleotide synthesis pathways
|
US20230218644A1
(en)
|
2020-04-16 |
2023-07-13 |
Som Innovation Biotech, S.A. |
Compounds for use in the treatment of viral infections by respiratory syndrome-related coronavirus
|
US11779572B1
(en)
|
2022-09-02 |
2023-10-10 |
Deciphera Pharmaceuticals, Llc |
Methods of treating gastrointestinal stromal tumors
|